INTERNATIONAL PATENT: ALTAY THERAPEUTICS, INC. FILES APPLICATION FOR "N-PHENYL-3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS DUX4 INHIBITORS FOR THE TREATMENT OF E.G. NEUROMUSCULAR DISORDERS"

GENEVA, April 30 -- ALTAY THERAPEUTICS, INC. (733 Industrial RoadSan Carlos, California 94070) filed a patent application (PCT/US2024/052155) for "N-PHENYL-3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS DUX4 INHIBITORS FOR THE TREATMENT OF E.G. NEUROMUSCULAR DISORDERS" on Oct 19, 2024. With publication no. WO/2025/085878, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OZES, Ali (c/o Altay Therapeutics, Inc.733 Industrial RoadSan Carlos, California 94070), LATIMER, Lee (c/o Altay Therapeutics...